32
docking and admet prediction of few gsk-3 inhibitors divulges 6-bromoindirubin-3-oxime as a potential inhibitor.pdf
docking and admet prediction of few gsk-3 inhibitors divulges 6-bromoindirubin-3-oxime as a potential inhibitor
13
6-bromoindirubin-3´-oxime suppresses lps-induced inflammation via inhibition of the tlr4_nf-kappab and tlr4_mapk signaling pathways.[2019][inflamma.pdf
6-bromoindirubin-3´-oxime suppresses lps-induced inflammation via inhibition of the tlr4_nf-kappab and tlr4_mapk signaling pathways.[2019][inflamma
24
Low-dose 6-bromoindirubin-3-oxime induces partial dedifferentiation of endothelial cells to promote increased neovascularization (R1).pdf
Low-dose 6-bromoindirubin-3′-oxime induces partial dedifferentiation of endothelial cells to promote increased neovascularization (R1)
19
Antiherpetic potential of 6-bromoindirubin-3-acetoxime (BIO-acetoxime) in human oral epithelial cells.pdf
Antiherpetic potential of 6-bromoindirubin-3′-acetoxime (BIO-acetoxime) in human oral epithelial cells
14
7-bromoindirubin-3-oxime uncovers a serine protease-mediated paradigm of necrotic cell death.pdf
7-bromoindirubin-3′-oxime uncovers a serine protease-mediated paradigm of necrotic cell death
8
6-Bromoindirubin-3oxime (BIO) decreases proliferation and migration of canine melanoma cell lines.pdf
6-Bromoindirubin-3′oxime (BIO) decreases proliferation and migration of canine melanoma cell lines
10
gsk3 inhibitors chir99021 and 6-bromoindirubin-3-oxime inhibit microrna maturation in mouse embryonic stem cells.pdf
gsk3 inhibitors chir99021 and 6-bromoindirubin-3′-oxime inhibit microrna maturation in mouse embryonic stem cells
0
induction of atypical cell death in thyroid carcinoma cells by the indirubin derivative 7-bromoindirubin-3-oxime (7bio):用靛玉红衍生物7-bromoindirubin-3-诱导甲状腺癌细胞非典型性细胞死亡肟(7bio).pdf
induction of atypical cell death in thyroid carcinoma cells by the indirubin derivative 7-bromoindirubin-3′-oxime (7bio):用靛玉红衍生物7-bromoindirubin-3′-诱导甲状腺癌细胞非典型性细胞死亡肟(7bio)

向豆丁求助:有没有bromoindirubin?

如要投诉违规内容,请联系我们按需举报;如要提出意见建议,请到社区论坛发帖反馈。